Narayan V, Dinney C
Urol Clin North Am. 2019; 47(1):93-101.
PMID: 31757304
PMC: 6986363.
DOI: 10.1016/j.ucl.2019.09.011.
Fakhrejahani F, Tomita Y, Maj-Hes A, Trepel J, De Santis M, Apolo A
Curr Opin Urol. 2015; 25(6):586-96.
PMID: 26372038
PMC: 6777558.
DOI: 10.1097/MOU.0000000000000213.
Newton M, Askeland E, Andresen E, Chehval V, Wang X, Askeland R
Clin Exp Immunol. 2014; 177(1):261-8.
PMID: 24593764
PMC: 4089175.
DOI: 10.1111/cei.12315.
Askeland E, Newton M, ODonnell M, Luo Y
Adv Urol. 2012; 2012:181987.
PMID: 22778725
PMC: 3388311.
DOI: 10.1155/2012/181987.
Nepple K, Aubert H, Braasch M, ODonnell M
World J Urol. 2009; 27(3):343-6.
PMID: 19479263
DOI: 10.1007/s00345-009-0429-6.
Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review.
Tinazzi E, Ficarra V, Simeoni S, Artibani W, Lunardi C
Rheumatol Int. 2005; 26(6):481-8.
PMID: 16220289
DOI: 10.1007/s00296-005-0059-2.
Immunotherapy for bladder cancer.
Kamat A, Lamm D
Curr Urol Rep. 2002; 2(1):62-9.
PMID: 12084297
DOI: 10.1007/s11934-001-0027-7.
Nitric oxide is an important mediator for tumoricidal activity in vivo.
Farias-Eisner R, Sherman M, Aeberhard E, Chaudhuri G
Proc Natl Acad Sci U S A. 1994; 91(20):9407-11.
PMID: 7937779
PMC: 44821.
DOI: 10.1073/pnas.91.20.9407.
Bladder instillation of adriamycin in the treatment of bladder cancer.
Huang C, Chiang C
Cancer Chemother Pharmacol. 1983; 11 Suppl:S91-3.
PMID: 6605814
DOI: 10.1007/BF00256728.
The effects of intravesical and intradermal application of a new B.C.G. on the dog bladder.
vd Meijden A, Steerenberg P, De Jong W, Bogman M, Feitz W, Hendriks B
Urol Res. 1986; 14(4):207-10.
PMID: 3787886
DOI: 10.1007/BF00441115.
Invasive bladder cancer--possible future treatment considerations.
Gardiner R
Urol Res. 1986; 14(4):191-4.
PMID: 3538608
DOI: 10.1007/BF00441112.
Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.
Rutten V, Klein W, de Jong W, Misdorp W, Steerenberg P, De Jong W
Cancer Immunol Immunother. 1991; 34(3):186-90.
PMID: 1756535
PMC: 11038549.
DOI: 10.1007/BF01742311.
